GlassScriptPhysician profile
Narinder R Bhullar
NPI 1821020140
$3,029.32
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $607 · 2021: $789 · 2022: $136 · 2023: $528 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $528 · Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $527.96 |
| Food and Beverage | $124.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $722.47 | 2019-2022 | |
| Livanova USA, INC. | $611.49 | 2019-2023 | Vns Therapy |
| Eisai INC. | $309.98 | 2020-2024 | |
| Acadia Pharmaceuticals INC | $292.97 | 2019-2020 | |
| Ucb, INC. | $208.38 | 2019-2022 | |
| Boston Scientific Corporation | $166.86 | 2021 | |
| Celgene Corporation | $131.78 | 2020-2022 | |
| Adamas Pharmaceuticals, INC. | $123.97 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $59.45 | 2020 | |
| Csl Behring | $46.97 | 2019 | |
| Amgen INC. | $46.82 | 2019 | |
| Lilly USA, LLC | $46.63 | 2019 | |
| Abbott Laboratories | $45.25 | 2019 | |
| Sk Life Science, INC. | $44.07 | 2020-2021 | |
| Abbvie INC. | $42.76 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $30.53 | 2020-2021 | |
| Kyowa Kirin, INC. | $27.84 | 2020 | |
| Amneal Pharmaceuticals LLC | $20.62 | 2019 | |
| Lundbeck LLC | $19.14 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.76 | 2019 | |
| Allergan, INC. | $15.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narinder Bhullar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.